Semaglutide can be used by adults and children aged 12 and older, while phentermine is approved for people aged 17 and older
When Tirzepatide May Not Be Recommended Tirzepatide may not be suitable for individuals with: A personal or family history of medullary thyroid cancer Multiple Endocrine Neoplasia Syndrome Type 2 Pregnancy or plans for pregnancy Certain gastrointestinal disorders A thorough screening ensures that this treatment aligns with your overall health profile
The window to shape the oral GLP-1 market is open now. Early-stage discussions with several multinational pharmaceutical companies currently underway KELOWNA, BC / ACCESS Newswire / March 24, 2026 / Lexaria Bioscience Corp
Oxidative stress and nuclear factor B (NF-B) increase peritoneal filtration and contribute to ascites formation in nephrotic syndrome
The natural pathogenesis of HIV consists of three stages: 1) the primary HIV infection phase, 2) the asymptomatic chronic phase, and 3) the late HIV symptomatic phase, which leads to an immunocompromised state resulting in increased susceptibility to opportunistic infections
Challenges with Self-Administration in the Upper Arm The upper arm is a great choice for semaglutide injection sites, but it does come with some challenges